calendar
19,572 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma
19,572 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma
no tagged catalysts yet
Anticipated earnings call for Monte Rosa Therapeutics, Inc. ($GLUE).
Anticipated earnings call for Oculis Holding AG ($OCS).
Anticipated earnings call for MBX Biosciences, Inc. ($MBX).
Anticipated earnings call for IOVANCE BIOTHERAPEUTICS, INC. ($IOVA).
Anticipated earnings call for Immunocore Holdings plc ($IMCR).
Anticipated earnings call for NOVAVAX INC ($NVAX).
Anticipated earnings call for UroGen Pharma Ltd. ($URGN).
Anticipated earnings call for CytomX Therapeutics, Inc. ($CTMX).
Anticipated earnings call for CRA INTERNATIONAL, INC. ($CRAI).
Anticipated earnings call for Xeris Biopharma Holdings, Inc. ($XERS).
Anticipated earnings call for Janux Therapeutics, Inc. ($JANX).
Anticipated earnings call for Cullinan Therapeutics, Inc. ($CGEM).
Anticipated earnings call for SpyGlass Pharma, Inc. ($SGP).
Anticipated earnings call for LEXICON PHARMACEUTICALS, INC. ($LXRX).
Anticipated earnings call for GYRE THERAPEUTICS, INC. ($GYRE).
Anticipated earnings call for TANDEM DIABETES CARE INC ($TNDM).
Anticipated earnings call for Sana Biotechnology, Inc. ($SANA).
Anticipated earnings call for ANI PHARMACEUTICALS INC ($ANIP).
Anticipated earnings call for Prime Medicine, Inc. ($PRME).
Anticipated earnings call for HARROW, INC. ($HROW).
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL